Study number 8539-627
Dates
Dec 04 2024-Dec 21 2024
Location
Daytona Beach, Florida
Age
18-65
Gender
Male or Female
Compensation
$5,683
Group
Part 1 Group 4b
This is a research study for an investigational drug being developed for the treatment of Primary Sjögren’s Syndrome, an autoimmune disorder in which the immune system mistakenly attacks healthy cells in the body.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Adults, age 18-65
- Body Mass Index between 18.5-30
- Study involves 1 stay of 9 overnights & 1 follow-up visit*
- Compensation up to $5,683 may be provided for time and participation*
- Refer a friend to receive $350 per qualified referral
*Additional out-patient visits may be required at the end of the study, resulting in additional compensation of up to
$163 per additional visit.
Call Now to Schedule Your Screening Appointment!
Part 1 Group 4b:
Check-in: Dec 4
Check-out: Dec 13
Follow up Visit: Dec 21